Michael S. Smith - 18 Feb 2026 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: Director
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 18 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 19 Feb 2026, 16:05:52 UTC
Previous filing: 25 Oct 2022
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Smith Michael S	Director	C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK	/s/ Adam C. Vandervoort, Attorney-in-Fact	19 Feb 2026	0001574979

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Award	$0	+53,648		$0.000000	53,648	18 Feb 2026	Common Stock	53,648		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2	One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.